Chemistry Nobel Goes to French-Japanese Pair for Cracking Century-Old 'Mirror Image' Molecule Mystery

The Royal Swedish Academy of Sciences announced on Wednesday that Henri Kagan of France and Kenso Soai of Japan have been awarded the 2026 Nobel Prize in Chemistry for resolving a puzzle that has confounded scientists for more than a hundred years: how chemical reactions can be steered to produce a single "handed" version of a molecule.

The two researchers were recognized "for the discovery of nonlinear effects and autocatalysis in asymmetric organic synthesis," according to the academy's citation. Their work revealed how chemical processes can be deliberately pushed to favor one molecular mirror image over another — a capability that has become indispensable for chemists designing reactions used in pharmaceutical manufacturing.

Kagan, 95, is based in France, while Soai, 76, works in Japan. Their combined contributions span decades of research into a phenomenon that touches the very foundations of how life organizes itself at the molecular level.

Many molecules critical to living systems come in two forms that are mirror images of each other, much like a person's left and right hands. These paired structures, known as enantiomers, share the same chemical formula but differ in their three-dimensional arrangement. Living organisms, however, almost exclusively rely on just one of the two versions — a trait scientists call "homochirality," drawing on the Greek term for hand.

This one-sidedness has never been fully explained. For over a century, researchers have asked why biology settled on a single handedness when ordinary chemical reactions tend to produce both mirror images in equal measure. The work by Kagan and Soai offered a mechanism showing how such selectivity can arise and even amplify itself.

Peter Somfai, a member of the Nobel Committee for Chemistry, explained the practical stakes of the discovery. "The left-handed version of the drug can have one effect, and the right-handed version can have another effect, and then we need methods for selectively preparing them," he said. "In developing such methods, the findings of this year's laureates are important. They provided powerful tools for that."

The pharmaceutical implications are significant. Because the two mirror images of a drug molecule can behave differently in the body — one potentially therapeutic, the other inactive or even harmful — the ability to produce only the desired form is a central challenge in drug development. The tools pioneered by the laureates give chemists a way to tilt reactions toward a single, chosen handedness.

Heiner Linke, who chairs the Nobel Committee, said the pair had supplied "a solution to a chemical mystery that is over a century old: how homochirality can emerge spontaneously." He described the chemical reactions they developed as "spectacular."

Soai learned of the honor in an unexpected setting. Speaking by telephone to the Nobel Prize news conference, he recounted that he had been out shopping when the call came through. "This is the most exciting day in my life, I am very glad to share this prize with Professor Henri Kagan," he said.

The chemistry prize is traditionally the third award handed out during Nobel week, following the announcements for medicine and physics. This year's medicine honor went to United States and German scientists for their work on optogenetics, while the physics prize recognized Francis Halzen for research on "ghost particles." The literature laureate is scheduled to be named on Thursday, with the highly anticipated peace prize following on Friday.

Last year's chemistry award was shared by Susumu Kitagawa, Richard Robson and Omar Yaghi for developing metal-organic frameworks — molecular constructions with potential applications ranging from climate change mitigation to addressing freshwater scarcity.

The Nobel Prizes were created through the will of Alfred Nobel, the Swedish inventor and businessman who died in 1896. Awards for achievements in science, literature and peace have been presented since 1901, with occasional interruptions, most notably during the two world wars. Nobel made his fortune in the 19th century from inventions tied largely to warfare, the most famous being dynamite. The economics prize is a later addition financed by Sweden's central bank.

This year's chemistry laureates tackled a question that sits at the intersection of fundamental science and industrial application. The concept of autocatalysis — in which a reaction's product accelerates its own formation — proved central to understanding how one handedness can come to dominate. Combined with insights into nonlinear effects, this provided a theoretical and practical framework for asymmetric synthesis.

The recognition of Kagan and Soai underscores how deeply foundational chemistry can ripple into real-world applications. Their work did not merely explain a natural curiosity; it gave synthetic chemists a set of reliable strategies for building molecules with the correct handedness, a requirement that runs through the production of countless medicines.

More than a century after scientists first puzzled over biology's preference for one mirror image over another, the academy's decision honors two researchers whose investigations turned that mystery into a usable set of chemical principles. Their findings now sit quietly behind many of the reactions that produce the drugs patients rely on every day.